pubmed-article:16441784 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C0005972 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C0018284 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:16441784 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:16441784 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16441784 | pubmed:dateCreated | 2006-1-30 | lld:pubmed |
pubmed-article:16441784 | pubmed:abstractText | Cyclopentenone prostaglandins have been shown to promote osteoblast differentiation in vitro. The aim of this study was to examine in a rat model the effects of local delivery of Delta(12)-prostaglandin J(2) (Delta(12)-PGJ(2)) on new bone formation and growth factor expression in (i) cortical defects and (ii) around titanium implants. | lld:pubmed |
pubmed-article:16441784 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:language | eng | lld:pubmed |
pubmed-article:16441784 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:citationSubset | D | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16441784 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16441784 | pubmed:month | Feb | lld:pubmed |
pubmed-article:16441784 | pubmed:issn | 0905-7161 | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:CooperLyndon... | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:OffenbacherSt... | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:SalviGiovanni... | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:DamrongsriDam... | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:GevaSarahS | lld:pubmed |
pubmed-article:16441784 | pubmed:author | pubmed-author:LimwongseVisa... | lld:pubmed |
pubmed-article:16441784 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16441784 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:16441784 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16441784 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16441784 | pubmed:pagination | 48-57 | lld:pubmed |
pubmed-article:16441784 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:meshHeading | pubmed-meshheading:16441784... | lld:pubmed |
pubmed-article:16441784 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16441784 | pubmed:articleTitle | Effects of Delta12-prostaglandin J2 on bone regeneration and growth factor expression in rats. | lld:pubmed |
pubmed-article:16441784 | pubmed:affiliation | Department of Anatomy, School of Dentistry, Chulalongkorn University, Bangkok, Thailand. | lld:pubmed |
pubmed-article:16441784 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16441784 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16441784 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |